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Rubella is an acute, contagious viral infection caused by a teratogenic enveloped single-
stranded RNA virus, rubella virus, a member of the togaviridae family. Though causing
generally mild infections in children and adults, it is a disease of public health importance
in pregnant women causing major problems including abortions, miscarriages, and con-
genital rubella syndrome in more than 20% of the susceptible population. This study was
carried out to determine the characteristics associated with rubella seronegativity among
female blood donors in Zambia. Rubella-specific IgG antibody levels were measured in the
blood serum. Proportions were compared using the Chi-squared test at the 5% significance
level, and magnitudes of associations were determined using the odds ratio and its 95%
confidence interval. Of the 124 female blood donors tested for rubella IgG 46.0% were
aged <20 years. Overall, 66.7% of the participants had never been married. More than half
(62.1%) of the participants resided in rural areas of the country. Of the 114 participants with
recorded level of education, 50.1% had at least completed secondary school. Out of 43
participants with recorded current employment status, 44.2% were not working for pay.
A total of 10 (8.1%) participants were seronegative to rubella IgG antibodies. No factors
were associated with seronegativity. Protection against rubella through natural infection
appears inadequate to protect the population, increasing the risk of CRS.
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INTRODUCTION
Rubella is an acute, contagious viral infection caused by a ter-
atogenic enveloped single-stranded RNA virus, rubella virus, a
member of the togaviridae family (1–3). Although the disease
affects both males and females, it is, however, a disease of public
health importance in pregnant women causing major problems
including spontaneous abortions, miscarriages, and congenital
defects including hearing impairment, heart defects, and cataracts
[congenital rubella syndrome (CRS)] in more than 20% of the
susceptible population (4–6). Rubella virus is the major cause of
birth defects among the TORCH group of agents (Toxoplasma,
Others, Rubella, Cytomegalo virus, and Herpes virus), which cause
congenital anomalies (7).
Rubella is vaccine-preventable and the primary objective of
rubella-control programs is prevention of congenital rubella virus
infection, which includes CRS (8). Control and prevention of
rubella infection is by immunization and therefore the World
Health Organization (WHO) recommends administration of
combined rubella and measles vaccines to young children, when-
ever feasible, to prevent CRS. Primary infection with rubella also
leads to immunity (9). Various strategies have been implemented
in different countries. Rubella immunization of adolescent girls
and susceptible women contemplating pregnancy are additional
control strategies. The United States (US) Centers for Disease
Control reported that universal vaccination of young children and
selective vaccination of susceptible women quickly resulted in the
elimination of CRS cases in US (4) and Americas (9). Hinman
and team suggested prioritizing protecting women of childbear-
ing age first, and then interrupting transmission of rubella (10).
Two live attenuated virus vaccines, RA 27/3 and Cendehill strains
were effective in the prevention of adult disease. However, their
use in prepubertile females did not produce a significant fall in
the overall incidence rate of CRS. Reductions were only achieved
by immunization of all children (11). The vaccine is now usually
given as part of the MMR and MR vaccine. The WHO recom-
mends that the first dose be given at 12–18 months of age with a
second dose at 36 months (12).
Understanding the specific epidemiology of rubella in a country
would help with determining the strategy to be used in prevention
and control of rubella and CRS. Rubella and CRS epidemiology is
poorly understood in most parts of the developing world including
Zambia with gaps in the serosurvey literature of rubella regard-
ing immunity across the entire age spectrum, among males and
females, and in varying settings that must be addressed (13). A
few seroprevalence studies have been conducted to determine the
susceptibility of women of child bearing age to rubella in the
developing world: a study to determine susceptibility to rubella
among women of child bearing age revealed 95.5% seropositivity
in Turkey (14); 90.1% in women 15–45 years of age in Senegal, and
84% in women 15–34 years of age in Côte d’Ivoire (15). Although
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it has already been established that rubella disease exists in Zambia
(16) with a seroprevalence of 91.9% among female blood donors
in Zambia (17), it is important to determine characteristics asso-
ciated with rubella seronegativity of the immunoglobulin G (IgG)
antibody among female blood donors aged 16 years or older in
order to inform policy on rubella-control strategy that can be
adopted for Zambia.
MATERIALS AND METHODS
The current study used data collected in a cross section study
among blood donors in Zambia (17). Details of the methodology,
which was used in that study, are highlighted below. Data were col-
lected from all the nine provincial headquarters (18). The sample
size was calculated using Statcalc program in Epi Info version 3.5.4
for population surveys and considering the following parameters:
rubella IgM positive seroprevalence rate of 76.9% (19), a popu-
lation size of 108,296, and an error of 5%, the required sample
size was 307. Totals of 203 males and 124 females participated in
the survey and only females were considered in the current study.
The sample size was proportionally allocated to provinces. Because
the total number of persons donating blood is small, all eligible
persons were requested to participate in the survey.
Blood donors are mostly students (70%). The study question-
naire included the following items: age, sex, residency, economic
status, education, reported rubella infection or vaccination, and
rubella IgG result (positive/negative IgG in ELISA test). The
questionnaire was pretested to ensure validity.
Blood samples were collected from consenting participants and
sent to the provincial laboratory for serum separation and storage
until transportation to the University Teaching Hospital, Virology
laboratory, for testing using the Enzyme Linked Immunosorbent
Assay (20). Anti-rubella-virus/IgG test result was considered neg-
ative if the difference in the optical densities between the antigen
and antigen control wells was<0.100, positive if the difference was
>0.200 and equivocal if the difference was from 0.100 to 0.200.
Epi Data version 3.1 was used to enter data and analysis was
conducted using SPSS version 16.0. About 75% of the participants
were aged below 25 years and in order to obtain valid statistical
results in cross tabulations, the factor age was categorized into
<20 years and 20 years or older age groups.
The Yates corrected Chi-squared test was used to determine
associations between qualitative factors in 2 by 2 tables. Mean-
while, the Pearson’s Chi-squared test was used to test associations
in contingency tables higher than 2 by 2. The cut off point for sta-
tistical significance was set at 5%. Magnitudes of association were
estimated using odds ratios and their 95% confidence intervals.
The research protocol was approved by the University of
Zambia Biomedical Research Ethics Committee Assurance No.
FWA00000338, IRB00001121 of IORG0000774. Permission to
conduct the study was obtained from the Zambia National Blood
Transfusion Services and Ministry of Health. Before administering
the questionnaire and obtaining a blood sample, study proce-
dures were explained to participants and consent to participate in
the survey was obtained. Participants were interviewed privately.
Results were shared with the blood bank for further dissemination
to their clients who participated in the survey and wished to know
their serostatus to rubella IgG.
RESULTS
A total of 124 female blood donors were tested for rubella infec-
tion of which 46.0% were aged <20 years. Table 1 shows the
distribution of socio-demographic and economic factors stratified
by age group. Overall, 66.7% of the participants had never been
married. More than half (62.1%) of the participants resided in
rural areas of the country. Of the 114 participants with recorded
level of education, 50.1% had at least completed secondary
school level of education or higher. Out of 43 participants with
recorded current employment status, 44.2% were not working
for pay.
About one in four (23.4%) of the participants resided in Lusaka
province (Figure 1). Most of the participants (62.1%) resided in
rural settings of Zambia.
Table 1 | Distribution of participants by socio-demographic and
economic factors stratified by age.
Factor Overall Aged <20
years
Age 20+
years
p value
n (%) n (%) n (%)
Marital status
Never married 80 (64.5) 55 (96.5) 25 (37.3) <0.001
Currently or once married 44 (35.5) 2 (3.5) 42 (62.7)
Residence
Urban 47 (37.9) 34 (59.6) 13 (19.4) <0.001
Rural 77 (62.1) 23 (40.4) 54 (80.6)
Education level
No formal school/up to
secondary school
63 (55.3) 26 (53.1) 37 (56.9) 0.826
Secondary school
completed/college/
pre-university or higher
51 (44.7) 23 (46.9) 28 (43.1)
Current employment
Government/non-
government/self
employed/employer
24 (55.8) 6 (42.9) 18 (62.1) 0.389
Not working for pay 19 (44.2) 8 (57.1) 11 (37.9)
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FIGURE 1 | Distribution of participants by province.
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A total of 10 (8.1%) participants were seronegative to rubella
IgG antibodies. Of the factors considered in the analysis, none of
them was significantly associated with rubella seronegative.
DISCUSSION
This study determined the characteristics associated with rubella
seronegative among female blood donors in Zambia between 16
and older. This study reveals a rubella susceptible population
(seronegative) of 8.1% among female blood donors in Zambia.
Although rubella has been eliminated in US, and in control in
other parts of the developed world it continues to be endemic in
many parts of the world. It is estimated that more than 100,000
infants are born with CRS annually worldwide (21). Rubella
still circulates in Zambia as evidenced through the measles case
based surveillance program that tests all negative measles cases for
rubella (16). Although literature confirms that in most countries
where there is no rubella immunization program, most children
should have gained natural immunity by age 15 years, there is
evidence of at least 5% women of child bearing age still being sus-
ceptible (5). This study reveals that the rubella immunity among
the female blood donors in Zambia was at 91.9% leaving a sus-
ceptible female population of 8.1%, which is within the range
determined by the three largest studies in Africa on women of
reproductive age that found that 6–16% were susceptible to rubella
virus infection (5). This relatively high rate must give concern. All
the rubella IgG seronegative participants were between 16 and
33 years of age (within the child bearing age) and this insinuates
an increased risk of CRS in this study population.
The current study endeavored to determine what demographic
and socio-economic factors including age, residency, education,
and employment among were associated with rubella seronega-
tivity. There was no significant association between any of these
factors and rubella seronegativity (Table 2). This lack of associa-
tion could be due to the small sample size and the majority of the
population (46.0%) being skewed toward the younger age group
below 24 years (Figure 2). The lack of association in the current
study may partly be due to most participants having similar eco-
nomic status. The study took place during school days and at
this time most blood collections are done at schools rather than
community based.
It is interesting to note that literature reveals increasing seropos-
itivity with increasing age while others showed advancing age to be
associated with reduced risk of rubella (22). However, in the cur-
rent study, no association was observed between age and rubella
seronegativity. Lack of adequate power in our study may explain
our finding.
Although our study agrees with some studies such as by Karakoc
et al. (23) that show no significant association of the outcome with
economic status, low socio-economic status has also been seen to
be associated with risk of rubella infection in other studies (24,
25). Our study agrees with authors such as Kombich et al. (25) that
found no association between education and rubella infection.
We note that type II error could have been minimum because
after the re-analysis for sample size based on the current study
proportion of seronegative females of 8.1%, population size of
48,733, and confidence limit of 5%, using statcalc program in
epi info version 7, the sample size should have been 114. In this
Table 2 | Factors associated with rubella seronegativity.
Factor IgG
total
IgG
negative (%)
OR (95% CI)
Age (years)
<20 57 6 (10.7) 1.38 (0.71, 2.66)
20+ 67 4 (6.0) 1
Marital status
Never married 79 9 (11.4) 2.35 (0.82, 6.72)
Currently or once married 44 1 (2.3) 1
Residence
Urban 47 6 (12.8) 1.62 (0.84, 3.14)
Rural 76 4 (5.3) 1
Education level
No formal school/up to
secondary school
63 3 (4.8) 0.61 (0.30, 1.24)
Secondary school
completed/college/
pre-university or higher
50 6 (12.0) 1
Current employment
Government/non-
government/self
employed/employer
24 3 (12.5) 1.60 (0.50, 5.19)
Not working for pay 19 1 (5.3) 1
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FIGURE 2 | Age distribution.
manuscript, we have a sample size of 124; therefore, the sam-
ple size in the study is adequate to estimate the proportion of
seronegativity.
The study though was limited to the blood donor population
who were mostly single; it is an important step in generating base-
line seroprevalence data on rubella infection in Zambia. The study
did not include most females who were married and in the child
bearing period of their lives. Hence, the prevalence of seronega-
tive women to assess the magnitude of the problem in this group
of females could not be assessed. It is known that false positiv-
ity may occur in persons treated for an immune system disorder,
those exposed to parvovirus, those with rheumatoid arthritis or
had a transfusion (26). This study did not control for any of these
possible confounders except rheumatoid factor during the testing
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procedure. Though the question as to whether one had had a blood
transfusion or received blood products were captured on the blood
donor form, it was not collected in this study. However, we believe
that the false positives would be minimal. Though no significant
association of age with outcome was found in this study it is noted
that 8.1% of the study population was still susceptible to rubella
infection by age of 16 years. Protection against rubella through
natural infection appears inadequate. We recommend the measles
vaccine be replaced with measles–rubella vaccine in the under-
five immunization program to prevent continued circulation of
the virus and a catch up campaign to include older children.
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